Position in ZTS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,291,675
-$695,686 QoQ
Shares Held
27,846
-12.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $7,470,447 across 34 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (44.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
27,846 | $3,291,675 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
88,173 | $1,221,196 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,056 | $626,186 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,651 | $456,536 | |
| 5 | VTRS |
Viatris Inc
|
26,426 | $357,015 | |
| 6 | HLN |
Haleon plc
|
30,272 | $303,022 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
96,254 | $263,735 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
1,776 | $233,970 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,291,675 | 27,846 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,987,361 | 31,691 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,133,051 | 35,081 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,622,309 | 36,052 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $5,942,383 | 36,091 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $6,031,179 | 37,017 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,382,042 | 37,783 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,546,246 | 37,761 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,166,181 | 36,441 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $7,511,704 | 38,059 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,550,694 | 37,652 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $6,102,605 | 35,437 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $5,632,828 | 33,843 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $615,510 | 4,200 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $680,354 | 4,588 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $826,962 | 4,811 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $954,642 | 5,062 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,359,247 | 5,570 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $973,223 | 5,013 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $888,378 | 4,767 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $689,604 | 4,379 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $731,841 | 4,422 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $751,110 | 4,542 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $483,888 | 3,531 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $408,031 | 3,467 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||